Stone Investment Group Limited » Performance Data » EuroPlus Dividend Growth Fund

Ideal for investors seeking total return tax efficient dividend income via European exposure, combining growth potential over the mid to long-term, dividend income, and lower risk than the MSCI Europe Index.

Daily Prices

Series Type Code Current NAVPS Prior NAVPS NAVPS Change Net Asset Value Last Updated
A Front SCL715 $ 14.4066 $ 14.3553 0.36% $ 20,835,101 2017-05-25
*B DSC SCL716 $ 13.7349 $ 13.6861 0.36% $ 340,555 2017-05-25
F Eligible SCL717 $ 15.7855 $ 15.7287 0.36% $ 5,396,184 2017-05-25
T8A Front SCL7158 $ 6.8871 $ 6.8625 0.36% $ 459,314 2017-05-25
L Low SCL719 $ 18.3196 $ 18.2546 0.36% $ 8,760,511 2017-05-25
* Closed to new purchases.

Series Rolling Returns (%)

Series 1 Month 3 Month 6 Month Year To Date 1 Year 3 Year 5 Year 10 Year Since Inception
A 7.4 18.0 13.8 14.7 15.9 5.8 12.3 n/a 3.9
Benchmark 6.3 14.1 16.6 12.9 20.6 6.4 14.0 n/a 4.1
B 7.4 17.8 13.4 14.5 15.1 5.2 11.5 n/a 3.4
Benchmark 6.3 14.1 16.6 12.9 20.6 6.4 14.0 n/a 4.1
F 7.5 18.4 14.5 15.3 17.2 6.9 13.4 n/a 5.0
Benchmark 6.3 14.1 16.6 12.9 20.6 6.4 14.0 n/a 4.1
L 7.4 17.9 13.4 14.5 15.2 5.2 11.7 n/a 10.8
Benchmark 6.3 14.1 16.6 12.9 20.6 6.4 14.0 n/a 4.1
T8A 7.4 18.0 13.7 14.7 15.7 5.7 12.2 n/a 3.9
Benchmark 6.3 14.1 16.6 12.9 20.6 6.4 14.0 n/a 4.1

Calendar Returns

CALENDAR RETURN 20162015201420132012201120102009200820072006
A -10.4 17.7 3.3 27.2 15.6 (0.1) (6.6) 13.1 (27.0)
B -11.0 17.1 2.7 26.4 14.7 (0.2) (7.1) 12.6 (27.2)
C 2.8 26.4 14.7 (0.3) (7.1) 12.6 (27.2)
F -9.6 19.0 4.4 28.5 16.9 0.4 (5.6) 14.1 (26.5)
T8A -10.6 17.8 3.3 27.1 15.7 0.3 (6.7) 12.4 (27.0)
T8B 2.9 26.8 14.9 (0.2) (7.1) 12.6 (27.2)
T8C 14.7 (0.3) (7.1) 12.4 (27.2)
L -11.0 17.2 2.8 26.6 15.0 (0.2)
Benchmark -3.1 15.7 2.5 33.8 16.6 (9.1) (1.2) 16.7 (32.3)
Benchmark: MSCI Europe $C

Growth of $10,000 Since Inception

Portfolio Composition (%)

Top Holdings (%)

HOLDINGS
1 Provident Financial plc 4.6
2 Novartis AG, Registered 4.6
3 Unilever NV 4.3
4 Newbelco SA/NV 4.2
5 Cerved Information Solutions SpA 4.2
6 Reckitt Benckiser 4.2
7 Kinepolis Group NV 4.0
8 Sampo Group 4.0
9 Reed Elsevier plc 3.8
10 Henkel AG & Co. 3.7
Total 41.6%

Fund Management Expense Ratio As of December 31, 2016

A B F L T8A
2.81 3.46 1.79 3.40 2.95